UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Effect of cryoprotectants on the stability and aerosol performance of nebulized aviscumine, a 57-kDa protein

European journal of pharmaceutics and biopharmaceutics, 2003-07, Vol.56 (1), p.11-21

2003

Volltextzugriff (PDF)

The preclinical and clinical activity of aviscumine: A potential anticancer drug

European journal of cancer (1990), 2011-07, Vol.47 (10), p.1450-1457

2011

Volltextzugriff (PDF)

Investigation of charge variants of rViscumin by two-dimensional gel electrophoresis and mass spectrometry

Electrophoresis, 2001-08, Vol.22 (14), p.2888-2897

2001

Volltextzugriff (PDF)

Abstract CT123: Aviscumine (ME-503), a plant protein with a novel mode of action, shows clinical activity in unresectable stage IV metastatic melanoma: data from a phase II trial

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT123-CT123

2016

Volltextzugriff (PDF)

ITOC2 – 019. An open-label multicenter phase II trial of aviscumine in previously treated patients with unresectable stage IV metastatic melanoma

European journal of cancer (1990), 2015-03, Vol.51, p.S7-S7

2015

Volltextzugriff (PDF)

Binding of Recombinant Mistletoe Lectin (Aviscumine) to Resected Human Adenocarcinoma of the Lung

Anticancer research, 2005-09, Vol.25 (5), p.3303-3307

2005

Volltextzugriff (PDF)

Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues

Biochemistry (Easton), 2004-03, Vol.43 (11), p.2996-3007

2004

Volltextzugriff (PDF)

Characterization of an arabinogalactan-protein isolated from pressed juice of Echinacea purpurea by precipitation with the β-glucosyl Yariv reagent

Carbohydrate research, 2000-08, Vol.327 (4), p.497-504

2000

Volltextzugriff (PDF)

Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study

Journal for immunotherapy of cancer, 2014-08, Vol.2 (1), p.27-27, Article 27

2014

Volltextzugriff (PDF)

The effect of formulation variables on the stability of nebulized aviscumine

International journal of pharmaceutics, 2003-05, Vol.257 (1), p.181-194

2003

Volltextzugriff (PDF)

Detection of rViscumin in plasma samples by immuno-PCR

Biochemical and biophysical research communications, 2003-01, Vol.300 (3), p.757-763

2003

Volltextzugriff (PDF)

Tumor‐associated CD75s gangliosides and CD75s‐bearing glycoproteins with Neu5Acα2‐6Galβ1‐4GlcNAc residues are receptors for the anticancer drug rViscumin

The FASEB journal, 2005-01, Vol.19 (1), p.103-105

2005

Volltextzugriff (PDF)

Adaptation and performance of an immuno-PCR assay for the quantification of Aviscumine in patient plasma samples

Journal of pharmaceutical and biomedical analysis, 2005-10, Vol.39 (5), p.972-982

2005

Volltextzugriff (PDF)

Adaptation and performance of an immuno-PCR assay for the quantification of viscumine in patient plasma samples

Journal of pharmaceutical and biomedical analysis, 2005, Vol.39 (5), p.972-982

2005

Volltextzugriff (PDF)

Mistletoe Lectin I Is a Sialic Acid-Specific Lectin with Strict Preference to Gangliosides and Glycoproteins with Terminal Neu5Acα2−6Galβ1−4GlcNAc Residues

Biochemistry (Easton), 2004-03, Vol.43 (11), p.2996-3007

2004

Volltextzugriff (PDF)

Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Ac[alpha]2-6Gal[beta]1-4GlcNAc-residues are receptors for the anticancer drug rViscumin

The FASEB journal, 2005, Vol.19 (1), p.103-105

2005

Volltextzugriff (PDF)

Characterization of recombinant and plant-derived mistletoe lectin and their B-chains

European journal of biochemistry, 1999-10, Vol.265 (2), p.788-797

1999

Volltextzugriff (PDF)

Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscumin

The FASEB journal, 2005-01, Vol.19 (1), p.103

2005

Volltextzugriff (PDF)

Deuteroporphyrin-IX-dimethylester: Zuordnung des 1H-NMR-Spektrums durch NOE-Messungen in Gegenwart eines diamagnetischen Verschiebungsreagens

Angewandte Chemie (International ed.), 1983-07, Vol.22 (S7), p.778-785

1983

Volltextzugriff (PDF)

Effect of excipients on the stability and aerosol performance of nebulized aviscumine

Journal of aerosol medicine, 2003-12, Vol.16 (4), p.417-432

2003

Volltextzugriff (PDF)

Deuteroporphyrin-IX-dimethylester: Zuordnung des1H-NMR-Spektrums durch NOE-Messungen in Gegenwart eines diamagnetischen Verschiebungsreagens

Angewandte Chemie International Edition, 1983-07, Vol.22 (S7), p.778-785

1983

Volltextzugriff (PDF)

Deuteroporphyrin‐IX Dimethyl Ester: Assignment of the 1 H‐NMR Spectrum by NOE Measurements in Presence of a Diamagnetic Shift Reagent

Angewandte Chemie International Edition, 1983-07, Vol.22 (7), p.551-552

1983

Volltextzugriff (PDF)

Cyanogenesis--a general phenomenon in the Lepidoptera?

Journal of chemical ecology, 1987-08, Vol.13 (8), p.1789-1809

1987

Volltextzugriff (PDF)

Deuteroporphyrin‐IX‐dimethylester: Zuordnung des 1H‐NMR‐Spektrums durch NOE‐Messungen in Gegenwart eines diamagnetischen Verschiebungsreagens

Angewandte Chemie, 1983-07, Vol.95 (7), p.563-563

1983

Volltextzugriff (PDF)

Deuteroporphyrin‐IX‐dimethylester: Zuordnung des 1 H‐NMR‐Spektrums durch NOE‐Messungen in Gegenwart eines diamagnetischen Verschiebungsreagens

Angewandte Chemie, 1983-07, Vol.95 (7), p.563-563

1983

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Humans
(8)
Ribosome Inactivating Proteins, Type 2
(8)
Aviscumine
(7)
Biological And Medical Sciences
(7)
Biochemistry & Molecular Biology
(6)
Medical Sciences
(6)
Animals
(4)
Pharmacology. Drug Treatments
(4)
Plant Proteins
(4)
Toxins, Biological - Chemistry
(4)
Chemistry
(3)
Drug Stability
(3)
General Pharmacology
(3)
Lectins - Chemistry
(3)
Nebulizers And Vaporizers
(3)
Oncology
(3)
Pharmacology & Pharmacy
(3)
Physical Sciences
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of cryoprotectants on the stability and aerosol performance of nebulized aviscumine, a 57-kDa protein

The preclinical and clinical activity of aviscumine: A potential anticancer drug

Investigation of charge variants of rViscumin by two-dimensional gel electrophoresis and mass spectrometry

Abstract CT123: Aviscumine (ME-503), a plant protein with a novel mode of action, shows clinical activity in unresectable stage IV metastatic melanoma: data from a phase II trial

ITOC2 – 019. An open-label multicenter phase II trial of aviscumine in previously treated patients with unresectable stage IV metastatic melanoma

Binding of Recombinant Mistletoe Lectin (Aviscumine) to Resected Human Adenocarcinoma of the Lung

Mistletoe lectin I is a sialic acid-specific lectin with strict preference to gangliosides and glycoproteins with terminal Neu5Ac alpha 2-6Gal beta 1-4GlcNAc residues

Characterization of an arabinogalactan-protein isolated from pressed juice of Echinacea purpurea by precipitation with the β-glucosyl Yariv reagent

Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study

The effect of formulation variables on the stability of nebulized aviscumine

Detection of rViscumin in plasma samples by immuno-PCR

Tumor‐associated CD75s gangliosides and CD75s‐bearing glycoproteins with Neu5Acα2‐6Galβ1‐4GlcNAc residues are receptors for the anticancer drug rViscumin

Adaptation and performance of an immuno-PCR assay for the quantification of Aviscumine in patient plasma samples

Adaptation and performance of an immuno-PCR assay for the quantification of viscumine in patient plasma samples

Mistletoe Lectin I Is a Sialic Acid-Specific Lectin with Strict Preference to Gangliosides and Glycoproteins with Terminal Neu5Acα2−6Galβ1−4GlcNAc Residues

Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Ac[alpha]2-6Gal[beta]1-4GlcNAc-residues are receptors for the anticancer drug rViscumin

Characterization of recombinant and plant-derived mistletoe lectin and their B-chains

Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscumin

Deuteroporphyrin-IX-dimethylester: Zuordnung des 1H-NMR-Spektrums durch NOE-Messungen in Gegenwart eines diamagnetischen Verschiebungsreagens

Effect of excipients on the stability and aerosol performance of nebulized aviscumine

Deuteroporphyrin-IX-dimethylester: Zuordnung des1H-NMR-Spektrums durch NOE-Messungen in Gegenwart eines diamagnetischen Verschiebungsreagens

Deuteroporphyrin‐IX Dimethyl Ester: Assignment of the 1 H‐NMR Spectrum by NOE Measurements in Presence of a Diamagnetic Shift Reagent

Cyanogenesis--a general phenomenon in the Lepidoptera?

Deuteroporphyrin‐IX‐dimethylester: Zuordnung des 1H‐NMR‐Spektrums durch NOE‐Messungen in Gegenwart eines diamagnetischen Verschiebungsreagens

Deuteroporphyrin‐IX‐dimethylester: Zuordnung des 1 H‐NMR‐Spektrums durch NOE‐Messungen in Gegenwart eines diamagnetischen Verschiebungsreagens

Suchergebnisse filtern